FONKSERA Trademark

Trademark Overview

On Monday, March 1, 2021, a trademark application was filed for FONKSERA with the United States Patent and Trademark Office. The USPTO has given the FONKSERA trademark a serial number of 90552345. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, May 3, 2024. This trademark is owned by H. Lundbeck A/S. The FONKSERA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention of depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety and apathy
fonksera

General Information

Serial Number90552345
Word MarkFONKSERA
Filing DateMonday, March 1, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, May 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention of depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety and apathy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressValby 2500
DK
Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressValby 2500
DK

Trademark Events

Event DateEvent Description
Thursday, March 4, 2021NEW APPLICATION ENTERED
Sunday, May 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 22, 2021ASSIGNED TO EXAMINER
Thursday, September 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 3, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, June 3, 2022TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Friday, June 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 6, 2022SOU TEAS EXTENSION RECEIVED
Monday, June 6, 2022SOU EXTENSION 1 FILED
Monday, June 6, 2022SOU EXTENSION 1 GRANTED
Wednesday, June 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 9, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 9, 2022SOU EXTENSION 2 FILED
Friday, December 9, 2022SOU EXTENSION 2 GRANTED
Tuesday, December 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 9, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 9, 2023SOU EXTENSION 3 FILED
Friday, June 9, 2023SOU EXTENSION 3 GRANTED
Tuesday, June 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023SOU EXTENSION 4 FILED
Tuesday, December 5, 2023SOU EXTENSION 4 GRANTED
Tuesday, December 5, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 5, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 5, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, December 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 3, 2024SOU EXTENSION 5 FILED
Friday, May 3, 2024SOU EXTENSION 5 GRANTED
Friday, May 3, 2024SOU TEAS EXTENSION RECEIVED
Saturday, May 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 22, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Friday, March 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

fonksera disorders pharmaceutical substances preparations central system nervous diseases prevention acting